Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

Lancet

Volumn 368, Issue 9538, 2006, Pages 843-854

  Bourhis, Jean ^a   Overgaard, Jens ^b   Audry, Hélène ^a   Ang, Kian K ^c   Saunders, Michele ^d   Bernier, Jacques ^e   Horiot, Jean Claude ^f   Le Maître, Aurélie ^a   Pajak, Thomas F ^g   Poulsen, Michael G ^h   O'Sullivan, Brian ⁱ   Dobrowsky, Werner ^j   Hliniak, Andrzej ^k   Skladowski, Krzysztof ^l   Hay, John H ^m   Pinto, Luiz HJ ⁿ   Fallai, Carlo ^o   Fu, Karen K ^p   Sylvester, Richard ^q   Pignon, Jean Pierre ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b Department of Experimental Clinical Oncology ^*  (Denmark)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d MOUNT VERNON HOSPITAL   (United Kingdom)

^e UNIVERSITY OF GENEVA   (Switzerland)

^f Department of Medical Oncology   (France)

^g RTOG Statistical Headquarters   (United States)

^h Radiation Oncology Mater Centre   (Australia)

ⁱ PRINCESS MARGARET HOSPITAL   (Canada)

^j NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^k INSTITUTE OF ONCOLOGY   (Poland)

^l INSTITUTE OF ONCOLOGY   (Poland)

^m BRITISH COLUMBIA CANCER AGENCY   (Canada)

ⁿ INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^o NATIONAL CANCER INSTITUTE   (Italy)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q EORTC DATA CENTER   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONFIDENCE INTERVAL; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; INTERMETHOD COMPARISON; LARYNX CARCINOMA; META ANALYSIS; METASTASIS; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33747881607     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)69121-6     Document Type: Article

References (29)

1. Ferlay J., Bray F., Pisani P., and Parkin D. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC Cancer Base number 5, version 2.0 (2004), IARC Press, Lyon, France
2. Pignon J., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 355 (2000) 949-955
3. Horiot J., LeFur R., N'Guyen T., et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25 (1992) 231-241
4. Pinto L., Canary P., Araujo C., Bacelar S., and Souhami L. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stage III and IV oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 21 (1991) 557-562
5. Cummings B., O'Sullivan B., Keane T., et al. 5-year results of 4 week/twice daily radiation schedule-the Toronto trial. Radiother Oncol 56 suppl 1 (2000) S8
6. Fu K., Pajak T., Trotti A., et al. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
7. Horiot J., Bontemps P., Van Den Bogaert W., et al. Accelerated fractionation compared to conventional fractionation improves locoregional control in the radiotherapy of advanced head and neck cancer: results of the EORTC 22851 randomized trial. Radiother Oncol 44 (1997) 39-46
8. Jackson S., Weir L., Hay J., Tsang V., and Durham J. A randomized trial of accelerated versus conventional radiotherapy in head and neck cancer. Radiother Oncol 43 (1997) 39-46
9. Overgaard J., Hansen H., Specht L., et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial. Lancet 362 (2003) 933-940
10. Olmi P., Crispino S., Fallai C., et al. Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy versus accelerated hyperfractionated radiotherapy versus concomitant radiotherapy and chemotherapy-a multicenter randomized trial. Int J Radiat Oncol Biol Phys 55 (2003) 78-92
11. Skladowski K., Maciejewski B., Golen M., Pilecki B., Przeorek W., and Tarnawski R. Randomized clinical trial on 7-days-continuous accelerated irradiation (CAIR) of head and neck cancer-report on 3-year tumor control and normal tissue toxicity. Radiother Oncol 55 (2000) 101-110
12. Hliniak A., Gwiazdowska B., Szutkowski Z., et al. A multicenter randomized/controlled trial of a conventional versus modestly accelerated radiotherapy in the laryngeal cancer: influence of a 1 week shortening overall time. Radiother Oncol 62 (2002) 1-10
13. Marcial V., Pajak T., Chang C., Tupchong L., and Stetz J. Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Oncology Group (RTOG). Int J Radiat Oncol Biol Phys 13 (1987) 41-47
14. Dische S., Saunders M., Barrett A., Harvey A., Gibson D., and Parmar M. A randomized multicentre trial of CHART vs conventional radiotherapy in head and neck cancer. Radiother Oncol 44 (1997) 123-136
15. Dobrowsky W., and Naudé J. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer. Radiother Oncol 57 (2000) 119-124
16. Poulsen M., Denham J., Peters L., et al. A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study. Radiother Oncol 60 (2001) 113-122
17. Bourhis J., Lapeyre M., Tortochaux J., et al. Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial. J Clin Oncol 24 (2006) 2873-2878
18. Pignon J., Sylvester R., and Bourhis J. Hyperfractionated and/or accelerated radiotherapy for head and neck cancer (protocol). The Cochrane Library, issue 2 (2000), Update Software, Oxford
19. Schemper M., and Smith T. A note on quantifying follow-up in studies of failure time. Control Clin Trials 17 (1996) 343-346
20. Yusuf S., Peto R., Lewis J., Collins R., and Sleight T. Beta blockade during and after myocardial infarction: an overview of randomised clinical trials. Prog Cardiovasc Dis 27 (1985) 335-371
21. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: an overview of randomized trials. N Engl J Med 333 (1995) 1444-1455
22. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 311 (1995) 899-909
23. Higgins J., and Thompson S. Quantifying heterogeneity in a meta-analysis. Stat Med 21 (2002) 1539-1558
24. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 death among 75 000 women. Lancet 339 (1992) 1-15
25. Datta N., Dutta Choudhry A., Gupta S., and Bose A. Twice a day versus once a day radiation therapy in head and neck cancer. Int J Radiat Oncol Biol Phys 17 suppl 1 (1989) 132-133
26. Stewart L., and Parmar M. Meta-analysis of the literature or meta-analysis of individual patient data: is there a difference?. Lancet 341 (1993) 418-422
27. Bourhis J., Le Maître A., Pignon J., et al. Impact of age on treatment effect in locally advanced head and neck cancer (HNC): two individual patient data meta-analyses. Proc Am Soc Clin Oncol 24 (2006) 280s
28. Khalil A., Bentzen S., Bernier J., et al. Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas. Int J Radiat Oncol Biol Phys 55 (2003) 568-575
29. Bourhis J., Armand C., Pignon J., and on behalf of the MACH-NC Collaborative Group. Update of MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemo-radiotherapy. Proc Am Soc Clin Oncol 22 (2004) 488